以下部分引用 AI 总结，现阶段 AI 仍然有幻觉。请以内容的原文为准。
数据新鲜度群聊 07-14 ✓卖方 07-14 ✓Wrap 断档15天 ✕News 07-15 ✓X 断档12天 ✕页面生成 07-15
$ARWR
13 atoms · 跨 1 天 · 首见 2026-05-01 · 最近 2026-05-01
三色: 🟦 fact 1 · 🟥 take 12 · stance ▲11/▼0/◆1
来源: X 13
时态: aging:5 · fresh:5 · stale:3
标签: 好观点:10 · 好数字:3
叙事 (narrative) (5)
- 2026-05-01
[老化中] · RNAi 产品管线多元化程度
ARWR holds a highly diversified RNAi portfolio targeting a spectrum of diseases
tags: 好观点 · → daily
value: direction=高
- 2026-05-01
[老化中] · 合作伙伴关系
strategically backed by multiple partnerships with reputable biotech/pharma players
tags: 好观点 · → daily
value: direction=多
- 2026-05-01
[老化中] · FCS 适应症作为滩头阵地
FCS as the beachhead indication
tags: 好观点 · → daily
value: date=现时
- 2026-05-01
[老化中] · Redemplo 在市场竞争中的定位
we believe Redemplo will compete well based on its overall clinical and once-quarterly dosing profile
tags: 好观点 · → daily
value: direction=强
- 2026-05-01
[老化中] · 资金状况
a well-capitalized position supported by partnerships
tags: 好观点 · → daily
value: direction=良好
预测 (forecast) (4)
- 2026-05-01 · 首个完整季度销售数据发布时间
first full-quarter sales numbers next week
tags: 好数字 · → daily
value: date=下周
- 2026-05-01 · sHTG 市场扩张计划
expanding into the much larger sHTG market pending SHASTA3/4 topline in the coming months (in 3Q)
tags: 好观点 · → daily
value: date=未来数月 (3Q)
- 2026-05-01 · 下一代管线
building the next pillar of its portfolio with early work ongoing in cardiovascular (e.g., DIMER), cardiometabolic/obesity (INHBE, ALK7), and CNS (MAPT)
tags: 好观点 · → daily
value: qty=心血管 (DIMER), 心脏代谢/肥胖 (INHBE, ALK7), 中枢神经 (MAPT)
- 2026-05-01 · 未来 6-12 个月数据催化
Over the next 6-12 months, multiple data cards from these programs will fall into place with greater granularity
tags: 好观点 · → daily
value: date=6-12个月
立场 (position) (3)
展开 3 条老旧 / 已过期
- 2026-05-01
[老旧] · JPMorgan 评级
JPMorgan Initiates Coverage on $ARWR with Overweight Rating, PT $88
tags: 好观点 · → daily
value: qty=Overweight · date=2026-05-01
- 2026-05-01
[老旧] · JPMorgan 目标价
JPMorgan Initiates Coverage on $ARWR with Overweight Rating, PT $88
tags: 好数字 · → daily
value: qty=$88 · date=2026-05-01
- 2026-05-01
[老旧] · JPMorgan 总体投资观点
ARWR holds multiple levers that investors can lean on for continued upside from today's valuation
tags: 好观点 · → daily
value: direction=上行
事实 (fact) (1)
- 2026-05-01 · 第一款商业化产品
its first commercial product, Redemplo (plozasiran)
tags: 好数字 · → daily
value: qty=Redemplo (plozasiran) · date=现时
时间轴 (近 20)
- 2026-05-01 ·
position · JPMorgan 评级 · → daily
- 2026-05-01 ·
position · JPMorgan 目标价 · → daily
- 2026-05-01 ·
narrative · RNAi 产品管线多元化程度 · → daily
- 2026-05-01 ·
narrative · 合作伙伴关系 · → daily
- 2026-05-01 ·
fact · 第一款商业化产品 · → daily
- 2026-05-01 ·
narrative · FCS 适应症作为滩头阵地 · → daily
- 2026-05-01 ·
forecast · 首个完整季度销售数据发布时间 · → daily
- 2026-05-01 ·
forecast · sHTG 市场扩张计划 · → daily
- 2026-05-01 ·
narrative · Redemplo 在市场竞争中的定位 · → daily
- 2026-05-01 ·
narrative · 资金状况 · → daily
- 2026-05-01 ·
forecast · 下一代管线 · → daily
- 2026-05-01 ·
forecast · 未来 6-12 个月数据催化 · → daily
- 2026-05-01 ·
position · JPMorgan 总体投资观点 · → daily
← 实体目录 · 系统日志